Epstein-Barr virus (EBV) is a human herpesvirus that establishes a chronic carrier state in almost one hundred per cent of the population world-wide. It has considerable importance as a pathogen associated with infectious mononucleosis, oral hairy leukoplakia, Burkitt's lymphoma, immunoblastic lymphomas of the immunosuppressed, nasopharyngeal carcinoma, T cell malignancy and Hodgkin's disease. A current model of pathogenesis suggests that EBV replicates productively in epithelial tissue of the oropharynx and establishes latency in B lymphocytes. Virus then trafficks between the two cell types as it enters the body and is periodically shed in saliva of infected individuals. The long term objective of this work is to understand the first steps in infection of both target cells of EBV which are critical to spread of virus within and between hosts. The immediate goals of this application are to use recently developed techniques for deriving EBV mutants to investigate the roles of known or putative EBV envelope proteins in the process. The phenotypes of mutated virus will be examined in vitro in primary B lymphocytes and in an SV40 transformed epithelial cell line that has been transfected with the B cell receptor for EBV. Phenotypes of mutated viruses will be examined in vivo in CB. 17 scid/scid immunodeficient mice engrafted with human lymphoepithelial tissue. There are three specific aims. The first is to examine the effects of deleting expression of proteins in the gp85 complex on the ability of virus to penetrate cells. Additional point mutations in gp85 will be evaluated for their effects on the integrity of the complex using recombinant proteins expressed in isolation; those that do not interfere with complex formation will then be built into virus for further functional analyses.
The second aim i s to examine the phenotype of virus deleted for expression of gp110, the EBV homologue of HSV-gB.
The third aim i s to determine whether or not four remaining potential virion membrane proteins are essential for virus replication, and to examine the location of each that proves to be so.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI020662-15
Application #
2633442
Study Section
Experimental Virology Study Section (EVR)
Project Start
1984-01-01
Project End
1999-12-31
Budget Start
1998-01-01
Budget End
1998-12-31
Support Year
15
Fiscal Year
1998
Total Cost
Indirect Cost
Name
University of Missouri Kansas City
Department
Biochemistry
Type
Schools of Medicine
DUNS #
800772162
City
Kansas City
State
MO
Country
United States
Zip Code
64110
Hutt-Fletcher, Lindsey M (2015) EBV glycoproteins: where are we now? Future Virol 10:1155-1162
Wu, Liguo; Hutt-Fletcher, Lindsey M (2007) Compatibility of the gH homologues of Epstein-Barr virus and related lymphocryptoviruses. J Gen Virol 88:2129-36
Wu, Liguo; Hutt-Fletcher, Lindsey M (2007) Point mutations in EBV gH that abrogate or differentially affect B cell and epithelial cell fusion. Virology 363:148-55
Wu, Liguo; Borza, Corina M; Hutt-Fletcher, Lindsey M (2005) Mutations of Epstein-Barr virus gH that are differentially able to support fusion with B cells or epithelial cells. J Virol 79:10923-30
Chen, Honglin; Huang, Jian; Wu, Frederick Y et al. (2005) Regulation of expression of the Epstein-Barr virus BamHI-A rightward transcripts. J Virol 79:1724-33
Guerreiro-Cacais, Andre Ortlieb; Li, LiQi; Donati, Daria et al. (2004) Capacity of Epstein-Barr virus to infect monocytes and inhibit their development into dendritic cells is affected by the cell type supporting virus replication. J Gen Virol 85:2767-78
Lake, Cathleen M; Hutt-Fletcher, Lindsey M (2004) The Epstein-Barr virus BFRF1 and BFLF2 proteins interact and coexpression alters their cellular localization. Virology 320:99-106
Borza, Corina M; Morgan, Andrew J; Turk, Susan M et al. (2004) Use of gHgL for attachment of Epstein-Barr virus to epithelial cells compromises infection. J Virol 78:5007-14
Chen, Honglin; Hutt-Fletcher, Lindsey; Cao, Liang et al. (2003) A positive autoregulatory loop of LMP1 expression and STAT activation in epithelial cells latently infected with Epstein-Barr virus. J Virol 77:4139-48
Huang, J; Chen, H; Hutt-Fletcher, L et al. (2003) Lytic viral replication as a contributor to the detection of Epstein-Barr virus in breast cancer. J Virol 77:13267-74

Showing the most recent 10 out of 31 publications